TABLE 2:
Percentage of RNA granules colocalized with ER | |||||
---|---|---|---|---|---|
Gene expressed | Cortical ER | Nuclear ER | Both | Non-ER | Total ER localization |
USE1 ORF + 3′UTR (full length) | 14.0 | 61.0 | 6.0 | 19.0 | 81.0 |
USE1 ORF (no 3′UTR) | 27.1 | 49.5 | 2.9 | 20.5 | 79.5 |
USE1 ORF + 3′UTR, no ATG | 15.8 | 68.0 | — | 16.2 | 83.8 |
USE1 ORF + 3′UTR, no ATGx2 | 50.1 | 18.6 | 1 | 30.3 | 69.7 |
USE1 ORF + 3′UTR, ∆TMD | 21.6 | 53 | 7.2 | 18.2 | 81.8 |
USE1 ORF, ∆TMD | 32 | 43 | 7 | 18 | 82.0 |
SUC2 ORF + 3′ UTR (full length) | 28.7 | 56.4 | 6.9 | 8 | 92.0 |
SUC2 ORF (no 3′ UTR) | 21.9 | 48.5 | 2.8 | 26.8 | 73.2 |
SUC2 ORF + 3′UTR, no ATG | 25 | 61.6 | 5 | 8.4 | 91.6 |
SUC2 ORF (no 3′ UTR), no ATG | 25.5 | 42 | 4.1 | 28.2 | 71.6 |
SUC2 ORF + 3′UTR, ∆SS | 22.8 | 53 | 3.3 | 20.9 | 79.3 |
SUC2 ORF (no 3′UTR), ∆SS | 11.9 | 52.4 | 5.9 | 29.8 | 70.2 |
FSH3 ORF + 3′UTR (full length) | 14.9 | 33.6 | 1.3 | 50.2 | 49.8 |
MS2L | 7.3 | 54.8 | 3.6 | 34.3 | 65.7 |